![Roel Bulthuis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roel Bulthuis
Investitore di Private Equity presso
SYNCONA LIMITED
Profilo
Roel Bulthuis currently works at Padlock Therapeutics, Inc., as Director from 2014, ONWARD Medical SA, as Director, NMD Pharma A, as Non-Executive Director from 2019, Scenic Biotech BV, as Director from 2019, iOnctura SA, as Director from 2020, QurAlis Corp., as Director from 2020, Salvia BioElectronics BV, as Director from 2020, Comet Therapeutics, Inc., as Director from 2019, Draupnir Bio ApS, as Director from 2019, Ambagon Therapeutics, Inc., as Director from 2019, Syncona Ltd., as Managing Partner from 2023, and Syncona Partners LLP, as Managing Partner & Head of Investments from 2023.
Mr. Bulthuis also formerly worked at Asceneuron SA, as Chairman, Translate Bio, Inc., as Director, Aveni SA, as Director from 2017 to 2019, Bird Rock Bio Sub, Inc., as Director, Canbex Therapeutics Ltd., as Director from 2012 to 2018, Vaximm AG, as Director, INKEF Capital BV, as Managing Director from 2019 to 2023, TocopheRx, Inc., as Director, Metabomed Ltd., as Director, Calypso Biotech SA, as Director, Merck Ventures BV, as Senior Vice President & Managing Director from 2015 to 2018, DNA Script SAS, as Director from 2018 to 2019, F-star Therapeutics, Inc., as Director from 2018 to 2019, GTX medical BV, as Non-Executive Director, and VarmX BV, as Member-Supervisory Board.
Mr. Bulthuis received his graduate degree from the University of Leiden and Masters Business Admin degree from Aalto University School of Business.
Posizioni attive di Roel Bulthuis
| Società | Posizione | Inizio |
|---|---|---|
| SYNCONA LIMITED | Investitore di Private Equity | 05/04/2023 |
Padlock Therapeutics, Inc.
 Padlock Therapeutics, Inc. BiotechnologyHealth Technology Develops medicines targeting protein-arginine deiminases | Direttore/Membro del Consiglio | 01/01/2014 |
Comet Therapeutics, Inc.
 Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders | Direttore/Membro del Consiglio | 01/01/2019 |
Salvia BioElectronics BV
 Salvia BioElectronics BV Medical SpecialtiesHealth Technology Develops neuromodulation devices and therapies for the treatment of migraine | Direttore/Membro del Consiglio | 01/01/2020 |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology Discovers and develops novel therapeutics for neuromuscular diseases | Direttore/Membro del Consiglio | 01/01/2019 |
Scenic Biotech BV
 Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Develops therapies for patients using genomics | Direttore/Membro del Consiglio | 01/01/2019 |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Direttore/Membro del Consiglio | 01/01/2020 |
iOnctura SA
 iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Direttore/Membro del Consiglio | 01/01/2020 |
Onward Medical SA
 Onward Medical SA BiotechnologyHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Direttore/Membro del Consiglio | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Precedenti posizioni note di Roel Bulthuis
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di Roel Bulthuis
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
70
Relazioni di 1° grado
29
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 29 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Syncona Ltd.
 Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Aveni SA
 Aveni SA Chemicals: Major DiversifiedProcess Industries Designs, develops, manufactures and markets chemical formulations | Process Industries |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bird Rock Bio Sub, Inc.
 Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Canbex Therapeutics Ltd.
 Canbex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of novel peripherally-acting cannabinoid agonists and mimetics for the treatment of multiple sclerosis spasticity and pain | Health Technology |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment | Commercial Services |
INKEF Capital BV
 INKEF Capital BV Investment ManagersFinance INKEF Capital invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Asceneuron SA
 Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders | Health Technology |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
Aalto University School of Business
 Aalto University School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TocopheRx, Inc.
 TocopheRx, Inc. Medical SpecialtiesHealth Technology Develops novel therapies for treatment of infertility | Health Technology |
Metabomed Ltd.
 Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
Calypso Biotech SA
 Calypso Biotech SA Pharmaceuticals: MajorHealth Technology Operates as a innovative biopharmaceutical company | Health Technology |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Develops medicines targeting protein-arginine deiminases | Health Technology |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Health Technology |
GTX medical BV
 GTX medical BV Medical SpecialtiesHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Health Technology |
NMD Pharma A/S
NMD Pharma A/S BiotechnologyHealth Technology Discovers and develops novel therapeutics for neuromuscular diseases | Health Technology |
Merck Ventures BV
 Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements. | Finance |
Varmx BV
 Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Health Technology |
Scenic Biotech BV
Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Develops therapies for patients using genomics | Commercial Services |
iOnctura SA
iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Health Technology |
DNA Script SAS
 DNA Script SAS Miscellaneous Commercial ServicesCommercial Services Engages in R&D, produce single-stranded DNA sequence nucleotide chemistries and microbiology consumables | Commercial Services |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Health Technology |
Salvia BioElectronics BV
Salvia BioElectronics BV Medical SpecialtiesHealth Technology Develops neuromodulation devices and therapies for the treatment of migraine | Health Technology |
Comet Therapeutics, Inc.
Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders | Health Technology |
Draupnir Bio ApS
 Draupnir Bio ApS BiotechnologyHealth Technology Operates as a biotechnology company that develops oral and small molecule degraders of extracellular diseases | Health Technology |
Ambagon Therapeutics, Inc.
 Ambagon Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops protein medicines | Health Technology |
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
